Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study

por Burkholz, Scott R., Herst, Charles V., Carback, Richard T., Harris, Paul E., Rubsamen, Reid M.
Publicado 2023

Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome

por Rubsamen, Reid, Burkholz, Scott, Massey, Christopher, Brasel, Trevor, Hodge, Tom, Wang, Lu, Herst, Charles, Carback, Richard, Harris, Paul
Publicado 2020

An Approach for a Synthetic CTL Vaccine Design against Zika Flavivirus Using Class I and Class II Epitopes Identified by Computer Modeling

por Cunha-Neto, Edecio, Rosa, Daniela S., Harris, Paul E., Olson, Tim, Morrow, Alex, Ciotlos, Serban, Herst, Charles V., Rubsamen, Reid Martin
Publicado 2017

Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications

por Wright, Sharon, Burkholtz, Scott R., Zelinsky, Cathy, Wittman, Connor, Carback, Richard T., Harris, Paul E., Blankenberg, Tikoes, Herst, Charles V., Rubsamen, Reid M.
Publicado 2023